24th International Workshop on Long-term Complications of HIV and SARS-CoV-2

第 24 届艾滋病毒和 SARS-CoV-2 长期并发症国际研讨会

• 批准号: 10548510
• 负责人: TODD T BROWN
• 金额: $ 5万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-01 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10548510
• 关键词: 2019-nCoV; Acute; Adverse effects; Affect; Age; Area; Award; COVID-19; Cardiovascular Diseases; Cause of Death; Chronic; Chronic Disease; Clinical; Clinical Management; Collaborations; Communities; Complement; Discipline; Disease; Educational workshop; Etiology; Europe; Event; Feedback; Fostering; Goals; HIV; HIV Infections; Home; Inflammation; International; Liver diseases; Long COVID; Longevity; Malignant Neoplasms; New York City; Oral; Pathogenesis; Pathogenicity; Patients; Persons; Physiological; Play; Post-Acute Sequelae of SARS-CoV-2 Infection; Program Development; Research; Research Personnel; Risk Factors; Role; Schedule; Scholarship; Stroke; Symptoms; Syndrome; System; Training Programs; Translational Research; Travel; Ursidae Family; Virus Diseases; Work; acute infection; antiretroviral therapy; career development; clinical practice; co-infection; comorbidity; coronavirus disease; disability; healthspan; improved; low and middle-income countries; meetings; multidisciplinary; peer; persistent symptom; posters; programs; research clinical testing; success

Project Summary With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including in low and middle income countries (LMIC). Large meetings are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. In addition, there is a need for a forum for scientific exchange regarding post-acute sequelae of COVID-19 (PASC), a poorly understood syndrome which may share pathogenic features with HIV comorbidities. Our workshop, now in its 24th year and renamed the International Workshop on Long-term Complications of HIV and SARS-CoV-2, provides <200 international delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity and PASC research in a one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. A highly interactive PASC roundtable, with 2-3 mini-talks, highlights critical and emerging issues in the pathogenesis and management of PASC. Abstract presentations including 26 15-minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 24th Workshop (November 5th/6th in New York City) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to provide a continued and expanded forum for discussion and dissemination of the latest research findings regarding PASC, 3) to support early-stage HIV Comorbidity and PASC investigators with a scholarship program and a Career Development Studio. By providing a “scientific home” to HIV Comorbidity and PASC investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and PASC and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH and those with long COVID.

项目概要 随着抗逆转录病毒疗法 (ART) 的成功，合并症现已成为主要原因 全球艾滋病毒感染者（包括中低收入人群）的死亡和残疾率 收入国家（LMIC）大型会议是有关科学交流的重要场所。 HIV 合并症研究的最新进展，但更小、更亲密的形式 强调讨论和网络对于艾滋病毒合并症的职业发展至关重要 此外，还需要一个关于急性期后的科学交流的论坛。 COVID-19 (PASC) 的后遗症，这是一种人们知之甚少的综合征，可能具有相同的致病性 我们的研讨会现已举办 24 年，并更名为国际研讨会。 HIV 和 SARS-CoV-2 长期并发症研讨会提供了 <200 个国际 代表们有机会聚集在一起讨论最新的发现和争议 HIV 合并症和 PASC 研究以一个房间、为期两天的形式进行。 来自艾滋病毒研究领域之外的专家或在特定领域具有专业知识的艾滋病毒研究人员 高度互动的 PASC 圆桌会议，包括 2-3 场小型演讲，重点讨论了关键和共病问题。 PASC 发病机制和治疗中出现的新问题。 包括 26 个 15 分钟的演讲和海报会议，为研究人员提供了一个示例机会 展示他们的最新工作并获得反馈，我们建议通过此 R13 来增强 24th。 研讨会（11 月 5 日/6 日在纽约市），其目标如下：1) 提供一个论坛 通过向中低收入国家研究人员提供旅行奖学金，开展中低收入国家最新的艾滋病毒合并症研究， 支持中低收入国家的国际公认非传染性疾病专家作为 全体会议发言人，并与国际培训项目联络，2) 提供持续和 扩大论坛讨论和传播有关 PASC 的最新研究成果， 3) 通过奖学金计划支持早期艾滋病毒合并症和 PASC 研究人员 以及职业发展工作室，为 HIV 合并症和 PASC 提供“科学之家”。 来自世界各地的研究人员，我们希望促进未来艾滋病毒的研究工作 合并症和 PASC，并促进研究结果转化为临床策略 可以延长感染者和长期感染者的寿命和健康寿命。